Contact Us →

Reducing Costs with Medication Reconciliation: PharmD Live®’s Team-Based Approach to Safer Transitions

Published: Revised:
Clinical pharmacist reviewing medications during a post-discharge care transition

As healthcare organizations accelerate their shift toward value-based care, medication reconciliation has emerged as a cornerstone for reducing healthcare spending and optimizing clinical outcomes.

Care transitions—specifically the shift from inpatient acute care or skilled nursing facilities back to the home—present a significant risk for medication discrepancies.

Unintentional drug omissions, duplicate therapies, unmonitored dosage modifications, and unaddressed drug-drug interactions are leading causes of post-discharge adverse drug events (ADEs).

These errors can compromise patient safety and contribute to avoidable readmissions and associated costs.

To bridge the gap between hospital discharge planners and outpatient care teams, medical groups, health systems, and Accountable Care Organizations (ACOs) deploy virtual clinical pharmacists.

Working alongside existing care teams, virtual pharmacists support post-discharge medication reconciliation and help identify medication-related risks.

The Hidden Cost of Medication Discrepancies During Care Transitions

When a patient transitions from an inpatient setting to outpatient primary care, their medication regimen is frequently altered.

Without immediate clinical oversight, these disruptions create severe clinical hazards and financial liabilities:

  • High Discrepancy Rates: A 2013 systematic review (Kwan et al.) found a median of 45% of patients had at least one unintended medication discrepancy across the hospital transition studies reviewed, rather than a uniform rate across all discharge timeframes.

  • Direct Cost of Preventable ADEs: A 2016 AJMC simulation modeling a discharged cardiovascular population estimated the 30-day cost of preventable ADEs under usual care at $472 per patient (in 2014 dollars).

  • High Discrepancy Volume: That same 2016 simulation estimated that 5,090 of 10,000 discharged cardiovascular patients would experience at least one medication discrepancy within 30 days without reconciliation.

While individual discrepancies do not trigger automatic penalties, downstream utilization affects organizations differently by program: CMS’s Hospital Readmissions Reduction Program (HRRP) adjusts hospital-level DRG payments for excess readmissions on tracked conditions, whereas ACOs, MIPS clinicians, and Medicare Advantage/Part D plans are evaluated separately through benchmark reconciliation, quality scores, or Star Ratings.

Clinical & Financial Value of Dedicated Oversight

Medication reconciliation is a formal, systematic process where clinical experts verify, update, and validate a patient’s complete medication history against their post-discharge orders.

Integrating virtual clinical pharmacists into this process transforms post-discharge care from a reactive administrative task into a high-yield clinical intervention.

Potential Clinical & Financial Impact

  • Modeled Cost Impact: Assuming a 52% reduction in discrepancies within a modeled cardiovascular discharge cohort, a 2016 AJMC simulation estimated 30-day ADE costs of $266 per patient with pharmacist-led reconciliation a $206 net benefit versus usual care (in 2014 dollars).

  • Modeled ADE-Related Rehospitalizations: Under those same model assumptions, ADE-related rehospitalizations (rather than all-cause readmissions) were projected to drop from 421 to 199 per 10,000 patients over 30 days.

  • Optimized Patient Safety & Adherence: Addressing medication discrepancies helps identify drug risks, clarify dosing schedules, and surface barriers to obtaining prescriptions.

Connecting Reconciliation to Clinical Outcomes

Hospital discharge orders can be complex, and outpatient teams may face capacity and coordination challenges when reconciling medications after discharge.

Delegating care transition reconciliations to clinical pharmacists working alongside the care team can help address the post-discharge safety gap:

PharmD Live® pairs virtual clinical pharmacists with technology-enabled workflows to support medication reconciliation across care transitions.

Operating as an extension of the outpatient care team, our virtual pharmacists identify and communicate post-discharge medication risks before the patient’s follow-up visit:

  1. Comprehensive Medication Management (CMM): Our Pharmacist Care Managers ingest hospital discharge summaries, cross-reference outpatient EHR profiles, and analyze active pharmacy fill data to catch hidden drug-drug interactions and duplicate therapies.

  2. Technology-Enabled Risk Identification: PharmD Live®’s technology can support identification of discharge patients who may benefit from medication review.

  3. Interprofessional Care Coordination & Documentation: Our Virtual pharmacists handle patient outreach, conduct step-by-step administration reviews, help address co-pay barriers, and document findings in the agreed care-team workflow.

PharmD Live® can support care teams with documentation for applicable CMS Transitional Care Management (TCM),Chronic Care Management (CCM), and Remote Patient Monitoring (RPM) standards.

Healthcare team coordinating medication reconciliation and follow-up after discharge

How Pharmacist-Led Reconciliation Operates in The Real-World

The tangible value of this operational bridge is demonstrated when catching life-threatening post-discharge duplicate therapies:

Mr. W.*, a 76-year-old patient discharged following coronary artery bypass graft (CABG) surgery, was sent home with five updated prescriptions.

During his hospital stay, his beta-blocker was switched from metoprolol tartrate to carvedilol.

Unaware that the metoprolol had been discontinued, Mr. W.* resumed taking his pre-admission bottle alongside his new carvedilol prescription.

Within 48 hours of returning home, he developed severe bradycardia (heart rate dropping below 40 bpm) and extreme dizziness.

As part of a TCM outreach protocol, a PharmD Live® Pharmacist Care Manager (PCM) conducted a comprehensive medication reconciliation within 48 hours of discharge.

The PCM identified the duplicate beta-blocker therapy, instructed Mr. W.* to immediately hold the old metoprolol bottle, notified his attending cardiologist, and updated his native EHR chart—stabilizing his heart rate and averting an emergency room readmission.

*Patient details and names have been anonymized to protect privacy in compliance with HIPAA guidelines.

Integrating Reconciliation into 2026 CMS TCM Rules

For eligible patients, medication reconciliation can be integrated into Centers for Medicare & Medicaid Services (CMS) billing frameworks—specifically Transitional Care Management (TCM).

Under current CMS Medicare Physician Fee Schedule rules, completing medication reconciliation on or before the date of the face-to-face visit is a mandatory billing requirement for TCM:

CPT Code Medical Decision-Making (MDM) Required Touchpoint Deadlines 2026 Medicare National Average Mandatory Reconciliation Rule
CPT 99495 Moderate Complexity MDM Interactive contact within 2 business days; face-to-face visit within 14 calendar days. ~$220.11 Medication reconciliation must be documented on or before the face-to-face visit date.
CPT 99496 High Complexity MDM Interactive contact within 2 business days; face-to-face visit within 7 calendar days. ~$298.60 Medication reconciliation must be documented on or before the face-to-face visit date.

Note: Figures reflect CY 2026 CMS PFS Non-Facility national unadjusted averages calculated using the $33.40 non-qualifying APM conversion factor. Payment varies based on Geographic Practice Cost Indices (GPCI).

Action Plan for Practice Leaders: Deploying Virtual Reconciliation

To support care coordination and reduce medication risk, executive leaders should take four immediate steps:

  1. Audit Discharge Discrepancy Rates: Review your health system or ACO panel data to measure 30-day readmissions tied to post-discharge medication confusion.

  2. Establish 2-Day Outreach Protocols: Deploy automated notifications to support interactive contact within 2 business days of discharge, as required for TCM.

  3. Embed Clinical Pharmacists into TCM Workflows: Delegate comprehensive medication reconciliations to virtual pharmacists working within applicable supervision and scope-of-practice requirements.

  4. Partner with a Turnkey Reconciliation Solution: Leverage PharmD Live’s pharmacist-led care model alongside Medication Therapy Management (MTM) to support risk stratification, timely reconciliation, and documentation in agreed workflows.

Drive Value-Based Success with Pharmacist-Led Reconciliation

Medication reconciliation is no longer just a regulatory checkbox—it is a vital financial and clinical strategy.

By deploying virtual clinical pharmacists to catch discrepancies during care transitions, healthcare organizations support patient safety, help address avoidable readmissions, and advance value-based care goals.

Contact PharmD Live® to discuss your medication reconciliation and TCM workflow.

References

  1. Centers for Medicare & Medicaid Services (CMS).Calendar Year (CY) 2026 Medicare Physician Fee Schedule Final Rule.CMS.gov.

  2. Centers for Medicare & Medicaid Services (CMS).Transitional Care Management (TCM) Services Booklet.CMS MLN Booklet.

  3. American Medical Association (AMA).CPT® 2026 Professional Edition: Transitional Care Management Guidelines.AMA Publishing.

  4. Kwan JL, Lo L, Sampson M, Shojania KG. Medication reconciliation during transitions of care as a patient safety strategy: a systematic review. Ann Intern Med. 2013 Mar 5;158(5 Pt 2):397-403. doi: 10.7326/0003-4819-158-5-201303051-00006.PMID: 23460096..

  5. Budnitz DS, Lovegrove MC, Shehab N, Richards CL.Emergency Hospitalizations for Adverse Drug Events in Older Americans. N Engl J Med. 2011;365(21):2002-2012. doi:10.1056/NEJMsa1103053.PMID: 22111719.

  6. Tenpas AS, Vascimini A, et al. Improvement in Clinical Outcomes and Access to Care With Pharmacist-Led Chronic Care Management Services at a Rural Family Medicine Clinic. J Pharm Pract. 2023;36(6):1392-1396. doi:10.1177/08971900221118232. PMID:35938485.

  7. PharmD Live®.Transitional Care Management & Medication Reconciliation Solutions.PharmD Live.

Cynthia C. Nwaubani, PharmD, BCGP & Divine C. Gama, BPharm
Stay Informed

Subscribe for More Insights

Get valuable clinical and healthcare resources delivered straight to your inbox.